NCT05049486

Brief Summary

This study aims to obtain finer details of tissues surrounding a lead in the pelvis using a combination of high-resolution anatomical MRI sequences and diffusion tensor imaging (DTI). DTI is a non-invasive technique sometimes described as fiber tractography that enables visualization of the pathways and integrity of nerves. In this feasibility study, we plan to use DTI to assess the sacral plexus and its peripheral nerves. A model will be constructed by superimposing SNS lead from a CT scan onto the DTI imaging to map out the electrode position. It is hoped that this study will lead to a better understanding of both therapeutic and adverse stimulation effects and enable patient-specific adjustments of stimulation parameters.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2017

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2017

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2017

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 26, 2018

Completed
21 days until next milestone

First Submitted

Initial submission to the registry

April 16, 2018

Completed
3.4 years until next milestone

First Posted

Study publicly available on registry

September 20, 2021

Completed
Last Updated

September 20, 2021

Status Verified

April 1, 2018

Enrollment Period

2 months

First QC Date

April 16, 2018

Last Update Submit

September 17, 2021

Conditions

Keywords

Sacral Nerve Stimulator;DTI;MRI;Faecal Incontinence;CT scan;

Outcome Measures

Primary Outcomes (1)

  • Implanting a lead around a nerve for finer details of tissues surrounding a sacral nerve stimulation lead.

    Size and distance of the sacral nerves from the implanted lead measured in millimetres (mm).

    12 months

Secondary Outcomes (1)

  • Stimulation of the sacral nerve using computational model induced electrical current to establish therapeutic range of SNS

    12 months

Study Arms (2)

MRI sequences and (DTI)

NO INTERVENTION

The aim of this study is to obtain finer details of tissues surrounding a lead in the pelvis using a combination of high resolution anatomical MRI sequences and diffusion tensor imaging (DTI). To do so, the patient will undergo a MRI scan (3 Tesla) of the pelvis using sequences including anatomical sequences and diffusion tensor imaging technique for construction of sacral nerve tractography prior to permanent SNS. This will be performed over an hour: first 30 minutes for anatomical sequences and the second 30 minutes for DTI sequencing.

CT scan

ACTIVE COMPARATOR

Three to 4 weeks after the procedure the patient will undergo a limited CT scan of the pelvis to visualise the position of the SNS lead. The scan will focus only on the sacrum, implanted lead, and rectum and will not be extended beyond this area. Imaging from this CT will be superimposed to the MRI imaging the patient had pre-operatively, and a computational simulation will be performed.

Radiation: CT scan

Interventions

CT scanRADIATION

Patients will undergone a pelvic CT scan.

CT scan

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients who are psychologically stable and suitable for intervention and able to provide informed consent
  • Patients with symptoms of faecal incontinence for solid or liquid stool
  • Patients who have had successful outcome from temporary SNS
  • Patients who are willing and competent to fill in questionnaires and undergo an extra CT and MRI scan during the study

You may not qualify if:

  • Patients who are claustrophobic to undertake MRI scan
  • Patients who had previous devices implanted that may be magnetically, electrically, mechanically activated or affected by MRI scan
  • Pregnant patients
  • Patients who are breastfeeding
  • Patients who are psychologically unstable and unsuitable for intervention and unable to provide informed consent
  • Patients who did not successfully pass the trial of SNS temporary SNS)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

London North West NHS Trust

Harrow, HA1 3UJ, United Kingdom

Location

Related Publications (6)

  • Jorge JM, Wexner SD. Etiology and management of fecal incontinence. Dis Colon Rectum. 1993 Jan;36(1):77-97. doi: 10.1007/BF02050307.

    PMID: 8416784BACKGROUND
  • Vaizey CJ, Carapeti E, Cahill JA, Kamm MA. Prospective comparison of faecal incontinence grading systems. Gut. 1999 Jan;44(1):77-80. doi: 10.1136/gut.44.1.77.

    PMID: 9862829BACKGROUND
  • Maeda Y, Lundby L, Buntzen S, Laurberg S. Outcome of sacral nerve stimulation for fecal incontinence at 5 years. Ann Surg. 2014 Jun;259(6):1126-31. doi: 10.1097/SLA.0b013e31829d3969.

  • Maeda Y, Lundby L, Buntzen S, Laurberg S. Suboptimal outcome following sacral nerve stimulation for faecal incontinence. Br J Surg. 2011 Jan;98(1):140-7. doi: 10.1002/bjs.7302. Epub 2010 Oct 27.

  • van der Jagt PK, Dik P, Froeling M, Kwee TC, Nievelstein RA, ten Haken B, Leemans A. Architectural configuration and microstructural properties of the sacral plexus: a diffusion tensor MRI and fiber tractography study. Neuroimage. 2012 Sep;62(3):1792-9. doi: 10.1016/j.neuroimage.2012.06.001. Epub 2012 Jun 13.

  • Cotterill N, Norton C, Avery KN, Abrams P, Donovan JL. A patient-centered approach to developing a comprehensive symptom and quality of life assessment of anal incontinence. Dis Colon Rectum. 2008 Jan;51(1):82-7. doi: 10.1007/s10350-007-9069-3. Epub 2007 Nov 15.

MeSH Terms

Conditions

Encopresis

Condition Hierarchy (Ancestors)

Signs and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and SymptomsBehavioral SymptomsBehaviorElimination DisordersMental Disorders

Study Officials

  • Carolynne Vaizey, FRCS

    London North West NHS Trust

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 16, 2018

First Posted

September 20, 2021

Study Start

October 1, 2017

Primary Completion

December 1, 2017

Study Completion

March 26, 2018

Last Updated

September 20, 2021

Record last verified: 2018-04

Data Sharing

IPD Sharing
Will not share

There is no plan to make IPD. Reserach results will be shared at the end of the study by local conferences and by peer scientific journals.

Locations